Understanding corticosteroid-sensitive and -insensitive pathways in airway remodelling

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/402423

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Asthma and chronic obstructive pulmonary disease (COPD) are chronic disorders of the airways affecting millions of people worldwide. Airways become remodelled, or thickened, resulting in airway obstruction and decline in lung function. Approximately 400 asthmatics and 6000 COPD sufferers die in Australia each year. Worryingly, COPD is currently the fourth highest cause of death in Australia and this number is predicted to increase in the future. Unfortunately, the drugs currently available for combating these diseases have limited success. We need to understand how to control airway remodelling to be able to improve treatments for asthma and COPD. But first we require a greater understanding of the molecular mechanism-s underlying the development of airway remodelling. With this proposal we will increase our knowledge of the mechanistic basis of asthma and COPD and may elucidate novel therapeutic targets for future pharmacological intervention.

Funded Activity Details

Start Date: 01-01-2006

End Date: 01-01-2008

Funding Scheme: NHMRC Project Grants

Funding Amount: $299,270.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

acute and chronic asthma | airway inflammation | airway remodelling | anti-inflammatory corticosteroids | cell proliferation | chronic airflow limitation (COPD) | cytokine production | fibrosis | mRNA stability

Related Links